TPRG1L
Tumor protein p63-regulated gene 1-like protein
Also known as: FAM79A, FLJ21811, h-Mover, RP11-46F15.3, SVAP30, TPRGL, TPRGL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T0D9
- Gene
- TPRG1L
- Ensembl
- ENSG00000158109
- Chromosome
- 1
- Canonical length
- 272 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
Predicted to enable calmodulin binding activity and identical protein binding activity. Predicted to be involved in presynaptic modulation of chemical synaptic transmission; regulation of glutamatergic synaptic transmission; and regulation of synaptic vesicle exocytosis. Predicted to act upstream of or within calcineurin-NFAT signaling cascade; negative regulation of synaptic transmission; and synaptic vesicle docking. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
272 residues, UniProt reviewed canonical sequence.
>Q5T0D9|TPRG1L
1 MLQLRDSVDS AGTSPTAVLA AGEEVGAGGG PGGGRPGAGT PLRQTLWPLS IHDPTRRARV
61 KEYFVFRPGS IEQAVEEIRV VVRPVEDGEI QGVWLLTEVD HWNNEKERLV LVTEQSLLIC
121 KYDFISLQCQ QVVRIALNAV DTISYGEFQF PPKSLNKREG FGIRIQWDKQ SRPSFINRWN
181 PWSTNVPYAT FTEHPMAGAD EKTASLCQLE SFKALLIQAV KKAQKESPLP GQANGVLILE
241 RPLLIETYVG LMSFINNEAK LGYSMTRGKI GFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TPRG1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 101 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 101 nTPM
- basal ganglia: 84 nTPM
- liver: 83 nTPM
- amygdala: 74 nTPM
- hippocampal formation: 72 nTPM
- hypothalamus: 68 nTPM
Single-cell type
- esophageal apical cells: 81 nCPM
- platelets: 79 nCPM
- hepatocytes: 68 nCPM
- retinal horizontal cells: 68 nCPM
- colonocytes: 59 nCPM
- enterocytes: 58 nCPM
Immune cell
- basophil: 21 nTPM
- neutrophil: 19 nTPM
- plasmacytoid DC: 8.9 nTPM
- MAIT T-cell: 7.6 nTPM
- naive CD8 T-cell: 7.2 nTPM
- memory CD4 T-cell: 6.7 nTPM
Brain region
- cerebral cortex: 122 nTPM
- pons: 112 nTPM
- basal ganglia: 108 nTPM
- hypothalamus: 106 nTPM
- hippocampal formation: 105 nTPM
- medulla oblongata: 94 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.78
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcineurin-NFAT signaling cascade
- negative regulation of synaptic transmission
- regulation of synaptic transmission, glutamatergic
- synaptic vesicle docking
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TPRG1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TPRG1L as an antibody target. Whether an autoantibody or antibody against TPRG1L could matter depends on whether native TPRG1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TPRG1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TPRG1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...